Abstract
90 % of thromboembolisms in patients with non-valvular atrial fibrillation are thought to arise from the left atrial appendage (LAA). Anticoagulation with Vitamin-K-antagonist is the current gold standard in stroke prevention. In recent years, several interventional devices have been developed to exclude the LAA and thus to minimize the risk of stroke. The present article reviews the problem, the concept, the technique and clinical efficacy of interventional LAA exclusion.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
